Trust in physicians and racial disparities in HIV care

AIDS Patient Care and STDs

Volumn 24, Issue 7, 2010, Pages 415-420

  Saha, Somnath ^a   Jacobs, Elizabeth A ^b   Moore, Richard D ^c   Beach, Mary Catherine ^c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN; RACE DIFFERENCE; TRUST; VIROTHERAPY; VIRUS INACTIVATION; VIRUS LOAD; CAUCASIAN; ETHNOLOGY; HEALTH CARE SURVEY; HIV INFECTIONS; MEDICATION COMPLIANCE; PSYCHOLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICAN AMERICANS; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; TRUST;

EID: 77954917973     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2009.0288     Document Type: Article

References (31)

1. Rand Health Resesarch. Disparities in care for HIV patients: results of the HCSUS study. RAND Health Research Highlights. Santa Monica, CA: RAND, 2006.
2. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005;38:96-103.
3. Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994;330:763-768.
4. Silverberg MJ, Leyden W, Quesenberry CP Jr, Horberg MA. Race/Ethnicity and risk of AIDS and death among HIV- infected patients with access to care. J Gen Intern Med 2009;24:1065-1072.
5. Halkitis P, Palamar J, Mukherjee P. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDS 2008;22:323-335.
6. Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ. The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr 2008;47:194-201.
7. Hartzell JD, Spooner K, Howard R, Wegner S, Wortmann G. Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care. J Acquir Immune Defic Syndr 2007;44:411-416.
8. Weintrob AC, Grandits GA, Agan BK, et al. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J Acquir Immune Defic Syndr 2009;52:574-580.
9. Klonoff EA, Landrine H. Do blacks believe that HIV/AIDS is a government conspiracy against them? Prev Med 1999;28: 451-457.
10. Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Ac- quir Immune Defic Syndr 2005;38:213-218.
11. Clark A, Mayben JK, Hartman C, Kallen MA, Giordano TP. Conspiracy beliefs about HIV infection are common but not associated with delayed diagnosis or adherence to care. AIDS Patient Care STDS 2008;22:753-759.
12. Bohnert AS, Latkin CA. HIV testing and conspiracy beliefs regarding the origins of HIV among African Americans. AIDS Patient Care STDS 2009;23:759-763.
13. Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment non- adherence among African American men with HIV. J Acquir Immune Defic Syndr 2009 Dec 1. [Epub ahead of print]
14. Stepanikova I, Mollborn S, Cook KS, Thom DH, Kramer RM. Patients' race, ethnicity, language, and trust in a physician. J Health Soc Behav 2006;47:390-405.
15. Halbert CH, Armstrong K, Gandy OH Jr, Shaker L. Racial differences in trust in health care providers. Arch Intern Med 2006;166:896-901.
16. Whetten K, Leserman J, Whetten R, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health 2006;96:716-721.
17. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
18. Jacobs EA, Rolle I, Ferrans CE, Whitaker EE, Warnecke RB. Understanding African Americans' views of the trustworthiness of physicians. J Gen Intern Med 2006;21:642-647.
19. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retro- virol 1998;17(suppl 1):S38-S41.
20. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments: Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
21. Mannheimer S, Thackeray L, Huppler Hullsiek K, et al. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care 2008;20: 161-169.
22. Gough IR, Furnival CM, Schilder L, GroveW. Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 1983;19:1161-1165.
23. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
24. Thrasher AD, Earp JA, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr 2008;49:84-93.
25. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read 1999;9:329-338.
26. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care 2000;12:405-408.
27. Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ. "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 2008;9:238-246.
28. Knafl GJ, Bova CA, Fennie KP, O'Malley JP, Dieckhaus KD, Williams AB. An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav 2008 Dec 24. [Epub ahead of print]
29. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 1997;87: 1773-1778.
30. Wynia MK, Gamble VN. Mistrust among minorities and the trustworthiness of medicine. PLoS Med 2006;3:e244.
31. Saha S. Rectifying institutional bias in medical research. Arch Pediatr Adolesc Med 2009;163:181-182.